Enter your keywords

Antidepressant drugs

This report looks at prescribing trends in primary care for Antidepressant drugs at CCG and STP level with particular focus on first choice antidepressant prescribing and exploration of associations between prescribing and improving access to psychological therapies. If you have any queries about the content of the report please contact us at nuth.nyrdtc.rxsupp@nhs.net Frequency Annually […]

Pain Management

This report looks at prescribing trends in primary care in relation to Pain Management at CCG and STP level with particular focus on Opioid and Non-opioid analgesics, Neuropathic pain, Antimigraine drugs and Osteoarthritis. If you have any queries about the content of the report please contact us at nuth.nyrdtc.rxsupp@nhs.net Frequency Bi-annually Data Period October 2018 […]

Drugs for Dementia

This report looks at prescribing trends in primary care for Drugs for Dementia at CCG and STP level with particular focus on low strength antipsychotics. Prescribing data is weighted with QoF registers. If you have any queries about the content of the report please contact us at nuth.nyrdtc.rxsupp@nhs.net Frequency Quarterly Data Period January 2019 to […]

Solriamfetol for obstructive sleep apnoea

Solriamfetol is indicated to improve wakefulness and reduce excessive daytime sleepiness (EDS) in adult patients with obstructive sleep apnoea (OSA) whose EDS has not been satisfactorily treated by primary OSA therapy, such as continuous positive airway pressure (CPAP). This publication reviews its efficacy and safety, and the limitations of the evidence. Solriamfetol is also licensed […]

Solriamfetol for narcolepsy

Solriamfetol is indicated to improve wakefulness and reduce excessive daytime sleepiness (EDS) in adult patients with narcolepsy with or without cataplexy. This publication reviews its efficacy and safety, and the limitations of the evidence. Solriamfetol is also licensed to improve wakefulness and reduce EDS in adults with obstructive sleep apnoea (see separate RDTC evaluation).

Impact of Priadel Price Change on CCG Prescribing Budgets

This bulletin aims to raise awareness of the NHS price increase for Priadel® (lithium carbonate) tablets as of November 2020 and the resulting cost impact to primary care. While discussions between the DHSC and the manufacturer of Priadel have prevented its discontinuation from the UK market at this stage, the renegotiated price in November 2020 […]

Optimising the use of morphine 10mg/5mL oral solution in primary care

Opioids are effective for acute pain and pain at the end of life, but there is little evidence of their effectiveness for long term pain. This document supports primary care teams to review patients receiving regular large quantities of morphine 10mg/5mL oral solution, and includes advice on how these patients could be managed. Download the […]

Safer Medication Use – Opioids and gabapentinoids

The use of combination opioids and gabapentinoids is associated with an increased risk of adverse events. Gabapentinoid overdose is much more likely to be fatal when combined with opioids and there is a greater risk of gabapentinoid dependence in patients with a history of opioid use disorder. There are limited circumstances when patients should be […]

Safer Medication Use – Ethanol in oral medicines for children

Ethanol is commonly used as an excipient in medicines, which is problematic in several patient groups but particularly so in children. The effects of chronic exposure to even small amounts of alcohol have not been well studied in children. In particular, phenobarbital elixir contains ethanol in such high amounts that children may ingest the equivalent […]